Do Young Park

Ajou University School of Medicine

Do Young Park MD PhD is currently an associate professor in Orthopedic Surgery, and director of Cell Therapy Center at Ajou University, Suwon, Korea. Dr. Park is also the CEO of AVANTRIX Ltd, a bio startup company developing novel tissue engineered solutions for arthritis patients. Main research interests include tissue engineering of articular cartilage, meniscus, and tendon-bone interfaces, translational research and clinical research. Dr. Park has over 50 related publications, 12 patents, and 5 ongoing national grantworks with aims of clinical translation of novel tissue engineered therapeutics for treatment of arthirtis.